Search research articles
Contact Us
Filters
Showing results (21-30 of 283) with videos related to
Page
of 29
Sort By:
International Journal of Molecular Sciences
|
June 2, 2021
The Contribution of Small Vessel Disease to Neurodegeneration: Focus on Alzheimer's Disease, Parkinson's Disease and Multiple Sclerosis
Federico Paolini Paoletti, Simone Simoni, Lucilla Parnetti, et al.
Biomarker Insights
|
October 28, 2020
Unraveling Pathophysiological Mechanisms of Parkinson's Disease: Contribution of CSF Biomarkers
Lucia Farotti, Federico Paolini Paoletti, Simone Simoni, et al.
The Lancet. Neurology
|
October 21, 2006
A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance
Paolo Calabresi, Barbara Picconi, Lucilla Parnetti, et al.
Frontiers in Neuroscience
|
June 10, 2021
Tracing Neurological Diseases in the Presymptomatic Phase: Insights From Neurofilament Light Chain
Lorenzo Gaetani, Lucilla Parnetti, Paolo Calabresi, et al.
Alzheimer'S Research & Therapy
|
January 17, 2019
Prevalence and risk of progression of preclinical Alzheimer's disease stages: a systematic review and meta-analysis
Lucilla Parnetti, Elena Chipi, Nicola Salvadori, et al.
BMJ Case Reports
|
December 21, 2018
Drug-induced Creutzfeldt-Jakob disease-like syndrome: early CSF analysis as useful tool for differential diagnosis
Federico Paolini Paoletti, Maria Di Gregorio, Paolo Calabresi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 20, 2016
Glucocerebrosidase in Parkinson's disease: Insights into pathogenesis and prospects for treatment
Anthony H V Schapira, Davide Chiasserini, Tommaso Beccari, et al.
Expert Review of Molecular Diagnostics
|
June 13, 2017
Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson's disease
Lucia Farotti, Silvia Paciotti, Anna Tasegian, et al.
Toxins
|
December 23, 2021
Botulinum Toxin for the Treatment of Hemifacial Spasm: An Update on Clinical Studies
Nicola Tambasco, Marta Filidei, Pasquale Nigro, et al.
Functional Neurology
|
August 2, 2008
Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease?
Barbara Palumbo, Donatella Siepi, Isabella Sabalich, et al.
Page
of 29
Search research articles
Search
Showing results (21-30 of 283) with videos related to
Sort By:
Page
of 29
International Journal of Molecular Sciences
|
June 2, 2021
The Contribution of Small Vessel Disease to Neurodegeneration: Focus on Alzheimer's Disease, Parkinson's Disease and Multiple Sclerosis
Federico Paolini Paoletti, Simone Simoni, Lucilla Parnetti, et al.
Biomarker Insights
|
October 28, 2020
Unraveling Pathophysiological Mechanisms of Parkinson's Disease: Contribution of CSF Biomarkers
Lucia Farotti, Federico Paolini Paoletti, Simone Simoni, et al.
The Lancet. Neurology
|
October 21, 2006
A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance
Paolo Calabresi, Barbara Picconi, Lucilla Parnetti, et al.
Frontiers in Neuroscience
|
June 10, 2021
Tracing Neurological Diseases in the Presymptomatic Phase: Insights From Neurofilament Light Chain
Lorenzo Gaetani, Lucilla Parnetti, Paolo Calabresi, et al.
Alzheimer'S Research & Therapy
|
January 17, 2019
Prevalence and risk of progression of preclinical Alzheimer's disease stages: a systematic review and meta-analysis
Lucilla Parnetti, Elena Chipi, Nicola Salvadori, et al.
BMJ Case Reports
|
December 21, 2018
Drug-induced Creutzfeldt-Jakob disease-like syndrome: early CSF analysis as useful tool for differential diagnosis
Federico Paolini Paoletti, Maria Di Gregorio, Paolo Calabresi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 20, 2016
Glucocerebrosidase in Parkinson's disease: Insights into pathogenesis and prospects for treatment
Anthony H V Schapira, Davide Chiasserini, Tommaso Beccari, et al.
Expert Review of Molecular Diagnostics
|
June 13, 2017
Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson's disease
Lucia Farotti, Silvia Paciotti, Anna Tasegian, et al.
Toxins
|
December 23, 2021
Botulinum Toxin for the Treatment of Hemifacial Spasm: An Update on Clinical Studies
Nicola Tambasco, Marta Filidei, Pasquale Nigro, et al.
Functional Neurology
|
August 2, 2008
Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease?
Barbara Palumbo, Donatella Siepi, Isabella Sabalich, et al.
Page
of 29